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ABSTRACT 
The heart is the first organ to become fully functional in the vertebrate embryo. 
Cardiomyocytes (CMs) are the major structural constituents of the heart and are severely 
affected in a heart failure situation. Through embryogenesis, mononucleated diploid CMs 
intensively proliferate but shortly after birth undergo terminal differentiation, which 
comprises sarcomere assembly and a drastic morphological rearrangement, from round 
to rod shape. This correlates with CMs’ cytokinesis blockage and cell cycle withdrawal, 
culminating in binucleation or polyploidy (according to the species) and cessation of 
proliferation. Subsequently, cardiac growth results from cell hypertrophy. While the 
mammalian heart has been considered a post-mitotic organ, devoid of intrinsic 
proliferative capacity, recent reports on CMs renewal in the adult murine and human 
hearts have challenged this longstanding dogma. However, the cellular renewal’s 
magnitude remains elusive due to tissue complexity, hurdles in isolating adult CMs and 
unavailability of specific CMs surface markers. Even though important advances have 
been made in recent years, distinct aspects of CMs maturation and differentiation remain 
elusive. For example, no data is available when considering the relationship between 
CMs’ morphometry and proliferation ability along ontogeny. Likewise, CMs’ cell cycle 
progression and/or duration remains poorly comprehended. 
This study set out to perform a detailed characterization of the CMs’ morphometry, 
nuclear and cell cycle dynamics, along mouse ontogeny. By combining a novel CMs 
isolation protocol with imaging flow cytometry we were able to successfully obtain a high 
yield of well-preserved CMs and collect quantitative data and imagery, enabling 
multiparametric analysis of CMs. Using ImageStreamX we demonstrated that at around 
embryonic day E17.5, CMs undergo elongation and multinucleation, resulting in 
rod-shaped cells with up to four nuclei at P10. Concerning the cell cycle and proliferation 
dynamics, our data demonstrate a gradual decrease of the cell cycle activity and mitotic 
CMs within the murine heart, as it matures along ontogeny. Finally, we have identified a 
stable and small fraction of immature mononucleated and round-shaped cells in the late 
developmental stages, which might putatively maintain mitosis-competence, being thus 
of potential therapeutic interest and the starting point for further studies. 
 
Keywords: cardiomyocytes, cell cycle status, heart, ImageStreamX, maturation, mitosis, 
ontogeny, proliferation. 
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RESUMO  
O coração é o primeiro órgão a tornar-se completamente funcional nos 
vertebrados. Os cardiomiócitos (CMs) são o principal constituinte estrutural do coração, 
sendo severamente afetados num cenário de doença cardiovascular. Durante a 
embriogénese dos mamíferos, CMs mononucleados e diplóides proliferam 
intensivamente, mas após o nascimento sofrem diferenciação terminal com maturação 
dos sarcómeros e rearranjo da morfologia da célula, que passa de circular para 
retangular. Este evento está correlacionado com um bloqueio da citocinese e 
consequente saída do ciclo celular, culminando em binucleação ou poliploidia 
(consoante a espécie) e no cessar da sua capacidade proliferativa. Consequentemente, 
o crescimento do coração resulta da hipertrofia dos CMs. O coração do mamífero adulto 
tem sido considerado um órgão pós-mitótico, desprovido de capacidade proliferativa. 
Contudo, relatos recentes de renovação celular nos corações de ratinho e humano 
adulto vieram contradizer este dogma. No entanto, a magnitude desta renovação celular 
permanece incerta, o que se deve à complexidade celular do coração, às dificuldades 
em isolar CMs adultos e à ausência de marcadores de superfície específicos para estas 
células. Apesar de nos últimos anos terem surgido novos dados sobre a maturação dos 
CMs, diferentes aspetos da sua biologia permanecem por esclarecer. Nomeadamente, 
não existem dados sobre a relação entre a morfologia dos CMs e a sua capacidade 
proliferativa. Para além disso, a progressão dos CMs no ciclo celular e a sua duração 
permanecem pouco caracterizadas.  
O presente estudo teve como objetivo realizar uma caracterização da dinâmica da 
morfometria, número de núcleos e ciclo celular dos CMs ao longo da ontogenia de 
murganho. Combinando um protocolo de isolamento novo com uma técnica de 
citometria de fluxo com imagem, conseguimos obter uma boa amostragem de CMs com 
estrutura preservada e recolher dados quantitativos das células. Usando o 
ImageStreamX demostrámos que, por volta do dia embrionário E17.5, os CMs sofrem 
elongação e multinucleação, resultando em células com forma de bastonete e que 
podem ter até quatro núcleos no dia pós-natal 10. Relativamente à dinâmica do ciclo 
celular e proliferação, os dados apontam para um decréscimo gradual do número de 
células ativas e mitóticas, à medida que o coração matura. Finalmente, foi também 
identificada uma pequena e estável fração de células imaturas, mononucleadas e 
redondas, nas fases finais da ontogenia, que poderão permanecer mitoticamente ativas, 
despertando assim interesse terapêutico e motivando o início de diversos estudos.  
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INTRODUCTION 
The adult heart: an overview 
The heart is a muscular organ, which synchronous contractions are responsible for 
supporting blood passage through the circulatory system, providing oxygen and 
nutrients, as well as removing metabolic wastes. Anatomically, the mammalian heart 
comprises four chambers which support a double-circulation system: two blood-receiving 
atria and two blood-pumping ventricles (Fig.1A). The right atrium receives venous blood 
from the whole body, through the venae cavae, passes it to the right ventricle, through 
the tricuspid valve, which pumps it into the pulmonary artery to the lungs. Oxygenated 
blood from the lungs, returns to the left atrium, via pulmonary arteries, and flows to the 
left ventricle (passing through the mitral/bicuspid valve), then being pumped into the 
aorta, to enter the whole-body systemic circulation (Lin et al., 2012). At the cellular level, 
the heart displays an astonishing complexity, comprising CMs, fibroblasts, hematopoietic 
and endothelial cells, vascular smooth muscle cells and specialized cells of the 
conduction system (Fig.1B). Conjointly these cells dynamically contribute to the 
structural, mechanical, chemical and electrical properties of an efficient heart, 
communicating with each other via autocrine, paracrine and cell-cell interactions (Harvey 
& Rosenthal, 1999). The heart wall exhibits a three-layered composition, encompassing 
the inner endocardium, a layer of endothelial cells lining the cardiac chambers and 
covering the heart valves; the myocardium, which is the thickest layer, composed of 
contractile cardiac muscle cells (cardiomyocytes – CMs); and the outer epicardium, 
constituted by epithelial cells. This is also the innermost layer of the pericardium, a 
double-walled sac which encloses the heart in the thoracic cavity (Fig.1). 
 
 
 
 
 
 
 
 
 
 
 
Fig.1 - The adult mammalian heart and its cellular complexity. A mature mammalian heart contains two atria, two 
ventricles and four valves determining the blood flow. The wall of each chamber consists of three tissue layers: 
endocardium, myocardium and epicardium. The main cellular components of the mature mammalian heart are contractile 
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cardiomyocytes, endothelial and hematopoietic cells, fibroblasts, smooth muscle vascular cells and specialized 
conduction system cells. Adapted from Xin et al. (2013).  
  
 
Cardiovascular diseases (CVDs) are the top cause of morbidity and mortality in the 
western world. World Health Organization (WHO) reported an estimated 17.3 million 
victims from CVDs in 2008, and by 2030 more than 23 million people are predicted to 
die annually from these disorders (WHO, 2010; WHO, 2011). 
Myocardial infarction (MI), or heart failure, is the most common cardiac disorder, 
and it is caused by occlusion of a coronary artery due to a blood clot or an atherosclerotic 
plaque, leading to myocardial ischemia and subsequent necrosis. Along with massive 
CMs death, the necrotic tissue is gradually replaced by a collagen scar, unable of 
contractile movements, diminishing the cardiac output and favoring the emergence of 
progressive compensatory pathologies (e.g. ventricular chamber dilation with wall 
thinning, arrhythmias, cardiogenic shock or a second MI) (Laflamme & Murry, 2005). 
Apart from heart transplantation and ventricular assist devices (electromechanical 
circulatory device used to partially or completely replace the function of a failing heart - 
Website 1), present-day therapies (thrombolytic drugs administration, bypass surgery or 
percutaneous coronary intervention), do not address the critical problem of a diminished 
pumping capacity, owing to a reduced pool of contractile muscle cells. Thus, for several 
years the focus of regenerative medicine has been on finding endogenous or external 
sources of cells to repopulate the injured area and stimulate intrinsic proliferation. These 
endogenous cells types, identified in mice and human, include the c-Kit (Beltrami et al., 
2003), Isl1 (Cai et al., 2003) and Sca1-positive (Matsuura et al., 2004) resident cardiac 
progenitors, side-population cells which are able to efflux Hoechst DNA dye (Pfister et 
al., 2005) and cardiospheres-derived stem cells (Messina et al., 2004). Exogenously 
delivered cell-based therapies using human embryonic stem cells (ESCs) or induced 
pluripotent stem cells (iPSCs) have also been proposed to repopulate the injured area 
and stimulate intrinsic proliferation (Laflamme et al., 2007; Matsuura et al., 2012). Some 
of these cells have even been used in clinical trials: ALCADIA (Takehara et al., 2008) 
and CADUCEUS (Makkar et al., 2012) used cardiospheres-derived stem cells, whereas 
SCIPIO (Bolli et al., 2011) used c-Kit-expressing cells. The efficiency of these 
approaches remains modest with two major concerns arising from their use: the patients’ 
safety during and after cell deliver, and tracking the cells to their ultimate destination, as 
diffusion to the blood circulation may occur, which can cause side-effects (Goldthwaite 
Jr, 2007). Low cell retention and engraftment in the healthy myocardium, low efficiency 
of cardiogenic differentiation and teratoma formation have also been hampering the 
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success of these regenerative therapies (Malliaras & Marban, 2011). Alternatively, the 
administration of exogenous growth factors or cytokines to stimulate uninjured 
cardiomyogenic progenitors or preexistent CMs adjacent to the injured area, is also 
under investigation (Kuhn et al., 2007). The adult mammalian heart has been considered 
as a post-mitotic organ due to its limited regenerative capacity. This contrasts with animal 
models such as zebrafish, which is capable of fully regenerating the heart after surgical 
resection of up to 20% of the ventricular region (Poss et al., 2002). This has been 
correlated with the proliferative capacity of CMs (Wills et al., 2008) and little inflammatory 
response after cardiac injury (Ieda et al., 2009). The longstanding dogma of the adult 
mammalian heart being devoid of intrinsic proliferation, has been however challenged 
by different observations. In 1998, Kajstura et al. (1998) demonstrated by 
immunocytochemistry a mitotic index of 14 proliferating CMs per million of myocytes in 
human diseased hearts (Kajstura et al., 1998). Ten years later, the radiocarbon-based 
tracing study of Bergmann et al. (2009) shown a CMs turnover’ rate of 1% per year at 
the age of 25, decreasing to 0.45% at the age of 75 (Bergmann et al., 2009). Recently, 
other reports of human CMs renewal arose, such as the one from Kajstura et al. (2010), 
in which the fraction of adult human CMs labeled by iododeoxyuridine ranged from 2.5% 
to 46%, and the one from Mollova et al. (2013), which demonstrated by 
immunofluorescence on myocardial samples-derived CMs, an extent of mitosis of 
~0.04% at birth and ~0.009% between the second decade of life (Kajstura et al., 2010; 
Mollova et al., 2013). After myocardial infarction, adult murine hearts also display a low 
extent of CMs replenishment ability (23% of CMs showed 15N-nuclear labelling, in 
contrast with 4.4% in unoperated mice, in Senyo et al. (2013) work). The observed 
proliferation is albeit insufficient to repair extensive injuries (Senyo et al., 2013). 
Remarkable CMs regenerative capacity has also been demonstrated during 
murine embryonic development (Drenckhahn et al., 2008) and in the early postnatal 
period upon cardiac injury (Porrello et al., 2011). However, the magnitude at which CMs 
renewal occurs is still under debate. In fact, the exact number of CMs within the murine 
adult heart remain uncertain, accounting from 15-56% of the total number of cardiac 
cells, based on histology and flow cytometry data (Nag, 1980; Vliegen et al., 1991; 
Banerjee et al., 2007). The inconsistencies in mammalian adult CMs’ proliferation rates 
reported in the literature (ranging from less than 1% to more than 40% per year) 
(Soonpaa & Field, 1997; Kajstura et al., 2010), are mainly due to difficulties in isolating 
and accurately identifying these cells within the cardiac tissue due to its inherent 
complexity and to the absence of specific cardiomyocytic surface markers. Current 
identification of CMs is mostly based on immunolabelling of components of the 
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sarcomeric apparatus (e.g. cardiac troponin T and I, sarcomeric α-actinin and α-actin). 
Therefore, decoding the mechanisms underlying the embryonic heart development and 
CMs’ maturation emerges as a crucial step to identify a specific marker and gain deeper 
insight into CMs’ biology. 
 
 
Mammalian cardiogenesis: an overview 
The heart is the first functional organ formed during embryonic development, due 
to its vital role in blood and nutrients supply (Lyons, 1996). Its formation is a complex 
morphogenic event dependent of coordinated contribution of cardiac progenitor cells, 
derived from three precursors pools spatiotemporally segregated in the developing 
embryo: cardiogenic mesoderm, cardiac neural crest and the proepicardium (Vincent & 
Buckingham, 2010). Cardiogenesis starts with the formation of the cardiogenic 
mesoderm during embryo gastrulation (murine embryonic day [E] 6.5) (Fig.2) - a key 
event where the three germ layers (endoderm, mesoderm and ectoderm) are formed, by 
ingression of the epiblast cells through the primitive streak (PS) (Tam et al., 1997). 
Cardiac mesodermal progenitor cells are then instructed to adopt a cardiac fate, forming 
two subpopulations. The path followed by these mesodermal progenitors to achieve full 
differentiation is rigorously controlled and regulated by numerous transcriptional cardiac 
regulators and signaling pathways, such as Wnt, Nodal and Notch (Freire & Resende, 
2014). The earliest subset, known as first heart field (FHF) migrates from the splanchnic 
mesoderm to an anterior-lateral position relative to the PS, and under the head folds, 
forming two bilaterally symmetrical cardiac regions. Once shaped, it expands and 
coalesce establishing the cardiac crescent. Lying underneath this structure emerges the 
second heart field (SHF), derived from the pharyngeal mesoderm (E7.5 - Fig.2) 
(Buckingham et al., 2005; Tzahor & Evans, 2011). The horseshoe-shaped cardiac 
crescent then suffers midline fusion forming the primitive cardiac tube (E8 - Fig.2), 
consisting of an outer layer of CMs (primitive myocardium) and an inner layer of 
endothelial cells (primitive endocardium). The first contractions occur at this stage, 
starting as peristaltic movements that progress into rhythmic contractions (Moorman & 
Christoffels, 2003). The heart tube rapidly expands through the recruitment of 
proliferating cells from the heart fields. While FHF contributes to the primitives left 
ventricle and atria, the SHF supports the primitive right ventricle and the outflow tract, a 
temporary embryonic structure that connects the ventricles with the aortic sac, ultimately 
generating the base of the ascending aorta and the pulmonary trunk.  
FCUP 
Restoring the heartbeat: Tracking cardiomyocyte proliferation 5 
 
At E8.5 rightward-looping occurs with the posterior region of the tube moving 
anteriorly to position the cardiac chambers for proper development (Fig.2) (Tzahor & 
Evans, 2011). Other cellular populations, such as the proepicardium and the cardiac 
neural crest, contribute at this stage to heart formation. The proepicardium (PE) is a 
transitory cell cluster that arises near the venous pole of the heart tube (E8.5). PE-
derived cells enclose the naked myocardium, forming the epicardium layer (E9.5-E11.5) 
(Cai et al., 2008), and some invade the heart experiencing epithelial-mesenchymal 
transition (EMT) [a biological process by which epithelial cells lose their cell polarity and 
cell-cell adhesions, assuming a mesenchymal phenotype with enhanced migratory and 
invasive properties, high resistance to apoptosis and absence of polarity, allowing their 
differentiation into a multiplicity of cell types (Kalluri & Weinberg, 2009)]. These cells 
differentiate into cardiac fibroblasts, coronary vessels’ smooth muscle and, and to a less 
extent into CMs and endothelial cells (Manner et al., 2001; Vincent & Buckingham, 2010). 
Recently, cell clusters with canonical stem-features (e.g. fibronectin encasement, 
vascular support) were described to be dispersed along the epicardial layer and 
suggested to have a role in the limited regenerative capacity of the adult heart in a 
cardiovascular disease setting (Balmer et al., 2014). Cardiac neural crest cells are a 
temporary subpopulation of cranial neural crest-derived cells, emergent from the dorsal 
neural tube (Kirby, 1987). These pluripotent cells actively migrate towards the heart at 
E10.5, guided by chemotactic routes after undergoing EMT, contributing for the aortic 
arteries development, myocardium septation, valve formation and for cardiac autonomic 
nervous system (Kuriyama & Mayor, 2008; Jain et al., 2011). 
By E14.5, the cardiac chambers are formed and the heart undergoes maturation. 
This comprises atria and ventricles’ septation, formation of the atrioventricular junction 
and the development of the atrioventricular cushions that will later give rise to the 
tricuspid and mitral valves (Marín-García, 2011). In the end, the heart achieves its final 
shape with a three-layered wall and fully-septated and well-defined cardiac chambers, 
connected to the pulmonary trunk and aorta. 
 
Fig.2 - Developmental stages of mammalian cardiogenesis. Myocardial progenitor cells ingress through the primitive 
streak (PS), migrating to the anterior of the embryo at about embryonic day (E) 6.5. These cells come to lie under the 
head folds (HFs), on each side of the PS, forming the first heart field (FHF) that will coalesce, resulting in the cardiac 
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crescent, where differentiated myocardial cells are now observed (E7.5). Underneath the cardiac crescent lies the second 
heart field (SHF), originated from the pharyngeal mesoderm. Next, the cardiac crescent expands, through recruitment of 
cells from FHF and SHF, fusing at the midline (ML) and forming the early beating heart tube (E8). Rightward-looping 
occurs (E8.5), resulting in the establishment of primitive ventricles and atria. After the looping, cardiac neural crest and 
proepicardium-derived cells contribute to the outflow tract (OFT) and epicardium development, respectively. By E10.5, 
the heart has acquired well-defined chambers, which by E14.5 become totally individualized by septation, and connected 
to the pulmonary trunk (PT) and aorta (Ao). IVS, interventricular septum; LA, left atrium; LV, left ventricle; PhA, pharyngeal 
arches; PLA, primitive left atrium; PRA, primitive right atrium; RA, right atrium; RV, right ventricle. Cranial (Cr)-caudal (Ca), 
right(R)-left (L) and dorsal (D)-ventral (V) axes are indicated. Adapted from Laugwitz et al. (2008).  
 
 
Ventricular wall: Trabeculation & Compaction 
Throughout cardiogenesis, myocardium layer displays polarized growth, resultant 
from oriented and exponential CMs division (Meilhac et al., 2004). At the heart-tube stage 
(E8 - Fig.3), the ventricular wall is composed by one or two cells-thick layer of contractile 
myocardium, a single-cell layer of endocardium and, sandwiched in between, cardiac 
jelly - an acellular gelatinous matrix secreted by the myocardium (Bartman & Hove, 
2005). As the heart tube undergoes rightward-looping, the ventricular myocardium 
thickens and the endocardial and inner myocardial layers invaginate (E9.5-E10.5 - Fig.3), 
forming myocardial trabeculae projected into the lumen and supported by a basal layer 
of compact myocardium (Zhang et al., 2013). The development of ventricular trabeculae 
is governed by signal transduction pathways involving the endocardium, myocardium 
and cardiac jelly. Trabeculae rapidly elongate, enhancing the contractile CMs’ force and 
the diffusion of oxygen and nutrients to the developing heart (E12.5-E13.5 - Fig.3) 
(Sedmera et al., 2000). Trabeculae expansion is achieved through proliferation of CMs, 
being that the proliferative capacity of the compact layer is significantly higher than that 
of the trabecular layer, exhibiting a 2-fold greater rate of cell division (Walsh, 2005). A 
transmural cell cycle gradient of decreasing proliferation and increasing differentiation of 
CMs is thus formed towards the apex of the trabeculae (Meilhac et al., 2003; de Boer et 
al., 2012). Around E14.5, the compact layer is highly proliferative and the trabeculae start 
to compact at their base, resulting in a compact and dense ventricular wall (Fig.3). From 
E16 onwards, the compact layer proliferates and matures into a complex and 
multilayered structure, and as a consequence of the increased contractile force required 
for systemic circulation, the compact layer of the left ventricle grows thicker than that of 
the right ventricle, in the adult mammalian heart (Risebro & Riley, 2006; Zhang et al., 
2013). 
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Fig.3 - Development of the ventricular wall. At E8.5, the cardiac tube is comprised by a thin layer of myocardium (red), 
separated by acellular cardiac jelly (grey) from the endocardium (grey). As it undergoes rightward-looping during E9.5-
E10.5, prominent trabeculae (grey arrows) emerge supported by a thin layer of proliferative compact myocardium. 
Elongation of trabeculae occurs during E12.5-E13.5. By E14.5 compaction occurs, contributing to the thickening and 
maturation of the ventricular wall, which is already covered by the epicardium (blue). Adapted from Zhang et al. (2013).  
 
 
Cardiomyocytes: Maturation and Differentiation 
Cardiomyocytes exhibit highly specialized components crucial for their proper 
function, i.e. to generate coordinated contractions for proper blood circulation: (1) 
sarcomeres, which are repetitive subunits of actin and myosin filaments tightly stacked, 
composing the basic mechanical unit to produce contractile force; and (2) intercalated 
discs (ICD), located at the cells’ apical ends, consisting of desmosomes, adherens 
junctions and gap junctions, that together mediate electro-mechanical coupling and 
intercellular communication (Sarantitis et al., 2012). 
 
Mammalian cells’ proliferation and differentiation are closely related to each other, 
and are regulated in an inverse fashion (Studzinski & Harrison, 1999). Myocardial growth 
occurs in two temporally distinct phases. During embryogenesis, heart growth occurs by 
hyperplasia, in which mononucleated diploid CMs with immature sarcomeres intensely 
proliferate (Oparil et al., 1984). Disassembly of the sarcomeric apparatus is crucial for 
proliferation, however the mechanisms responsible for sarcomere collapse and their 
de novo formation are not totally comprehended (Kaneko et al., 1984; Ahuja et al., 2004). 
In the first two weeks following birth, major alterations occur in CMs and after the fifth 
postnatal day (P5) (Leu et al., 2001), cardiac growth occurs essentially by CMs 
hypertrophy (around 30-40 fold cell volume increase) (Oparil, 1985). In mammals, this 
neonatal transition is linked with terminal differentiation and according to the species, it 
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is accompanied by CMs binucleation (mouse) or polyploidization (human), both 
correlating with the onset of CMs cell cycle withdrawal to a quiescent G0 phase. In mice, 
this neonatal transition is marked by extensive CMs binucleation between P5-P10 
resulting from a final round of acytokinetic mitosis, with up to 90% of adult murine CMs 
becoming binucleated during the first two postnatal weeks (P0-P14) (Soonpaa et al., 
1996; Soonpaa & Field, 1997). In contrast, by the onset of puberty most of human CMs 
are mononucleated and polyploid, with ploidy as high as 64N (Laflamme & Murry, 2011; 
Mollova et al., 2013). A considerable fraction (25%) of binucleated diploid (2x2N) cells is 
also reported to exist in the adult heart (Olivetti et al., 1996; Steinhauser & Lee, 2011). 
With terminal differentiation, CMs cellular dimensions and shape are also 
drastically restructured. Hirschy et al. (2006) characterized CMs’ transformation along 
maturation: longitudinal growth results from increased myofibrils’ length and number, 
their tight stacking and re-orientation into a parallel orientation (Fig.4). This drastic 
reorganization of the cell cytoarchitecture is accompanied with ICD formation and 
redistribution. ICD present a circumferential pattern in early embryonic CMs and is 
restricted to the cell’s apical ends by birth (Fig.4) (Perriard et al., 2003; Hirschy et al., 
2006). Major alterations are also detected in the expression of contractile proteins-coding 
genes, such as replacement of α-skeletal actin and β-MHC in the murine fetal heart by 
α-cardiac actin and α-MHC. As a result of these modifications, the sarcomeric apparatus 
becomes denser and more complex in the early neonatal stages, providing a better 
adaptation to the after-birth systolic load intensification (Ng et al., 1991; Driesen et al., 
2009). Simultaneously, the expression pattern of the connexin (Cnx) protein family 
(present in gap junctions) changes: Cnx-40 and -45 predominate in embryonic CMs, 
being later replaced at E18.5 by the isoform Cnx-43 (Delorme et al., 1997; Hirschy et al., 
2006). The switch in the cardiac genetic profile is also complexly linked with the 
remodeling of the epigenetic context. Embryonic CMs display histone modifications for 
active genetic expression of proliferation-related genes, such as hyperacetilation 
(H3K9/14ac, H3K18ac, and H3K27ac) and phosphorylation of histone H3 (H3S10ph, 
considered a hallmark of mitosis). Extensive chromatin condensation (heterochromatin) 
resultant from its deacetilation (at H3K9/14, H3K18, and H3K27) and methylation 
(H3K9me2/3 and H3K27me3) is observed throughout CMs terminal differentiation, 
culminating in transcriptional repression of embryonic cardiac genes and upregulation of 
adult cardiac-specific genes together with the silencing of cell cycle genes (Sdek et al., 
2011; Oyama et al., 2014). 
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Fig.4 - Schematic representation of the changes in cellular shape, myofibril alignment and cell-cell contact 
organization that take place in CMs during mouse heart development. The early embryonic CMs (E12) have a round 
shape, few myofibrils (grey), and adherens junctions (orange) and desmosomes (blue) homogenously distributed. Around 
E14, CMs elongation initiates with myofibrillar alignment, but the cell–cell contacts are still broadly distributed. By E18, 
the adherens junctions begin to be restricted to the apical ends of the CMs, where the myofibrils are inserted, and the gap 
junctions (green) are still located in the lateral surface. The final arrangement of the intercalated discs is achieved only 
after birth, with the cell-cell contacts being totally restricted to the polar ends. Reproduced from Perriard et al. (2003).  
 
 
Cell cycle withdrawal: a multifactorial event 
The typical mammalian cell cycle, by which cells divide, is composed of interphase 
(G1, S and G2 phases) and M-phase (mitosis), which culminates with karyokinesis and 
cytokinesis. Cell cycle progression entails a tightly regulation by cyclins and their targets, 
the cyclin-dependent kinases (CDKs). In mammals, cyclins-CDKs complexes are 
sequentially formed and regulated to orchestrate coordinated entry into the next phase 
of the cell cycle. Cytokinesis is the final step of mitosis culminating in the physical division 
of the two daughter cells, with proper inheritance of both nuclear and cytoplasmic 
contents. This cell cycle phase consists of a chain of events involving: (1) the 
establishment of the division plane; (2) furrow ingression by the actinomyosin contractile 
ring, which position in the cell’s cortex is defined by distinct proteins, such as anillin; (3) 
formation of the midbody, a transitory cytoskeletal structure that localizes the site of 
abscission; and finally (4) cell separation in a process called abscission (Field & Alberts, 
1995; Glotzer, 2001). 
 
Several studies have focused on the genetic and molecular changes associated 
with CMs cell cycle arrest, but the multifactorial network governing this event remains 
largely uncharacterized and unknown. In the course of ontogeny, cyclins and CDKs 
expression and activity levels oscillate in a synchronous manner, consequently affecting 
CMs proliferation ability. Cyclins-CDKs expression levels reach a peak at E12 
approximately, decreasing until P0 causing a concomitant decline in CMs proliferation, 
as demonstrated by Western blot analysis in Ikenishi et al. (2012) report (Ikenishi et al., 
2012). In the timeframe surrounding P5, CMs terminally differentiate and undergo 
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binucleation and many cell cycle-related mediators and inhibitor are upregulated, namely 
(Pasumarthi & Field, 2002; Ikenishi et al., 2012; Mahmoud et al., 2013; Tane et al., 
2014a). From this point onwards, a progressive downregulation of the expression and 
activities of cyclins and CDKs is observed. This is associated with silencing of cell cycle-
related and cytoskeleton organization-related genes leading to cell cycle arrest, as 
shown by microarray analysis in Gan et al. (2015). 
During embryonic and early neonatal development, both DNA replication and 
cytokinesis occur in the vast majority of CMs (Fig.5A). Terminal differentiation causes 
cytokinesis blockage leading to binucleation, and distinct mechanisms have been 
proposed to explain this failure: (1) sarcomeres incomplete disassembly due to gradual 
increased complexity along CMs maturation, physically impairing the separation of 
daughter cells (Fig.5B) (Li et al., 1997a; Li et al., 1997b); (2) incorrect formation of the 
contractile ring and assymetric furrow ingression due mislocation to the midbody of 
anillin, which is diffusely located in the cell cortex and hinders proper abscission (Fig.5C) 
(Engel et al., 2006). Recent work by Naqvi et al. (2014) suggested that binucleated CMs 
are able to successfully undergo cytokinesis. The mechanisms underlying this division 
are however not totally understood (Naqvi et al., 2014). 
Our understanding of the mechanisms underlying CMs proliferation has increased 
significantly in recent years. During murine development these cells gradually cease to 
proliferate as they terminally differentiate. This also includes the transition from a round 
to rod-like cellular morphology, multinucleation and cell cycle withdrawal. Despite being 
commonly accepted that CMs withdraw from the cell cycle shortly after birth, progression 
through the cell cycle and its duration remain largely unknown. Furthermore, the 
association between CMs’ morphometry and cell cycle status is also poorly characterized 
and it may unveil some clues about the proliferation cessation during mammalian 
ontogeny. 
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Fig.5 - Possible scenarios for cytokinesis occurrence in murine CMs. (A) Embryonic and neonatal CMs undergo 
successful cytokinesis which includes full sarcomeres’ disassembly, correct furrow ingression and positioning of anillin in 
the midbody, forming two mononucleated diploid (2N) CMs. Terminally differentiated CMs fail cytokinesis due to (B) 
sarcomere incomplete disassembly resulting in binucleated CMs, or (C) incorrect formation of the contractile ring and 
assymetric furrow ingression due to mislocation of anillin. 
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AIMS 
 
Current regenerative strategies based on proliferation of cardiomyocytic 
progenitors has so far delivered modest results. Therefore the current main focus of 
research turned to the development of approaches to trigger renewal of preexisting CMs 
and/or to increase cardiomyogenic precursor cells activity. However, there are several 
inconsistencies and unanswered questions in the field, which are mainly related with 
technical difficulties such as efficient isolation of intact CMs and lack of CMs markers. In 
this context, deeper insight on CMs maturation and proliferation is essential. Thus, the 
herein research work aimed to: 
 
 
 
i. perform a detailed characterization and quantification of CMs’ nuclei and 
morphometric dynamics throughout embryonic, early postnatal and adult murine life.  
ii. evaluate cell cycle status and proliferation of CMs within the developing murine heart, 
in the course of ontogeny. 
 
 
The knowledge here acquired will provide new insights on the events underlying 
CMs maturation and development, allowing to develop tools to identify dividing CMs and 
to launch novel studies regarding the proliferation cessation and cell cycle withdrawal 
phenomena. This work also intends to overcome technical limitations related with the 
isolation and characterization of developing CMs, which has been hindering further 
studies in this area. The identification of a stable and small fraction of immature and 
putatively mitotic competent CMs within the heart is thus of potential therapeutic interest, 
providing the basis for further studies.
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MATERIALS & METHODS 
Animal model: C57BL/6J mice 
C57BL/6J mice (Mus musculus) were bred and maintained at the IBMC·INEB 
Animal Facility in accordance with animal care and bioethical committee guidelines. All 
experiments involving animals were done in compliance with the relevant laws and 
institutional guidelines and were approved by local and European ethic committees 
(Directive 2010/63/EU). 
 
 
Harvesting and flash-freeze of murine hearts 
Embryonic stages 
 To collect E10.5, E13.5 and E17.5 murine hearts, timed-pregnant females were 
used (the day of the vaginal plug was designated E0.5). For embryo dissection, the 
mother’s abdomen was opened to expose the uterine horns, which were excised to a 
Petri dish with ice-cold phosphate-buffered saline (PBS). Under a stereomicroscope 
(Olympus SZX-FOF coupled to a Olympus KL 1500 LCD light source) and using fine 
forceps, decidua were isolated and the uterine muscular wall, Reichert's membrane and 
visceral yolk sac were separated from the actual embryo (Fig.6). After harvesting, hearts 
were immediately flash-frozen in liquid nitrogen stored at -80ºC. 
 
 
Fig.6 - Dissection procedure of E10.5 embryo for heart harvesting. (a) After opening the abdominal cavity of the time-
pregnant female, the uterine horns are carefully pulled out with forceps. Scale bar: 0.5 cm. (b,c) Decidua are then 
separated with scissors, and the embryo is removed with the placenta and yolk sac attached and intact (d). (e) Placenta 
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and Reichert's membrane surrounding the yolk sac are torn open. (f,g,h) To isolate the embryo, the yolk sac is then torn 
open with fine forceps, and the heart is harvested. Scale bar in d-g: 1 mm. Adapted from Boisset et al. (2011).  
 
Postnatal and adult stages 
After euthanasia of postnates’ (P0, P3, P7, P10, P15 and P24), hearts were 
harvested and placed on ice-cold cardioplegic solution (4 mM KCl in PBS) to accomplish 
asystole. Adult hearts were either collected and placed in ice-cold cardioplegic solution 
or perfused with 4% (v/v) paraformaldehyde (PFA). For cardiac perfusion, the animal 
was firstly anesthetized via intraperitoneal injection of 0,17mg/30g sodium pentobarbital. 
Once the animal became unconscious, the abdomen was opened to expose the 
inferior/caudal vena cava, where a catheter, connected to the peristaltic pump, was 
placed to perfuse with PFA for 15 min. To assure proper perfusion, the portal vein was 
also cut. The heart was then collected and placed on ice-cold PBS. 
After removing the associated vessels and fat, the tissue was minced in 
approximately 2 mm2 blocks, flash-frozen in liquid nitrogen and stored at -80ºC. 
 
 
Isolation of murine cardiomyocytes 
For CMs isolation, flash-frozen tissue was first fixed in 4% (v/v) PFA, at room 
temperature (RT) for 2 hours while stirring (≈ 110 rpm). After rinsing once with PBS for 
5 min, the tissue was enzymatically digested overnight (ON), at 37ºC on a rotator 
(110 rpm), with 3 mg/mL collagenase type II (Worthington) in Hank's Balanced Salt 
Solution with Ca2+ and Mg2+ (HBSS, Sigma-Aldrich). Once full digestion was achieved, 
HBSS supplemented with 10% fetal bovine serum (FBS, Gibco) solution was added to 
inhibit collagenase activity. Next, a 390g centrifugation for 10 min at 4ºC was performed 
and cells were ressuspended in 3% FBS in PBS. Cells were counted in a 
hemocytometer. 
 
 
CMs cytospins: immunocytochemistry and analysis 
Enzymatically dissociated CMs’ preparations (Table 1) were centrifuged at 239g 
for 7 min, ressuspended in 10% FBS in PBS and cytospun (Shandon Cytospin®, Thermo) 
for 5 min at 130g onto Superfrost® Plus slides (VWR).  
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Table 1 - Optimal CMs suspensions’ cell density for cytospin smears. 
Mouse ontogenic stage Optimal CMs density per staining 
E10.5 - E17.5 0.15 x 106 cells 
P0 - P10 0.05 x 106 cells 
P15 - Adult  0.01 x 106 cells 
 
Afterwards, a permeabilization step with 0.5% Triton X-100 in PBS was performed 
for 7 min, in case of intracellular/nuclear antigens’ staining. Primary (Table 2) and 
secondary antibodies were diluted in 3% FBS in PBS or in 0.02% Tween-20 in PBS, if 
permeabilization was required. The primary antibody incubation was carried out for 
1-2 hours on ice. After three washes with the antibody diluent, 1 min each, incubation 
with secondary antibodies (1:1000, Life Technologies) was performed for 1 hour on ice. 
DNA was stained with 4’6-diamidino-2-phenylindole (DAPI) (1:10000, Vector 
Laboratories), and the slides mounted in mounting medium containing 2.5% (m/v) 
n-propyl-gallate (Sigma-Aldrich) in 10% PBS and 90% glycerol. 
Representative images were acquired on Axiovert 200M inverted fluorescence 
microscope (Zeiss) (63x and 100x magnitude) and ImageJ® (FiJi 1.49t) was used to 
measure the cells’ area, maximal (corresponding to the major axis) and minimal 
(corresponding to the minor axis) feret diameters and aspect ratio (ratio of the major axis 
to the minor axis). 
 
 
ImageStreamX: immunocytochemistry 
Cardiomyocytes’ suspensions (with ≈0.5x106 cells) were plated on a 96-well plate, 
centrifuged at 424.84g for 1 min and ressuspended in 3% FBS in PBS. Antibodies were 
diluted in this buffer: primary antibody’s (Table 2) incubation was carried out for 2 hours, 
on ice, followed by secondary antibodies for 40 min. The secondary antibody was chosen 
considering the detection channels available for the ImageStreamX system. Stained cells 
were ressuspended in PBS until analysis. Non-stained and single-stained controls were 
also included for spectral compensation. For nuclear staining, far-red fluorescent nuclear 
DNA dye DRAQ5® (200 μM, Biostatus) was added to the samples prior acquisition.
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Table 2 - List of primary antibodies used for immunocytochemistry (ICC) and immunohistochemistry (IHC), with the specific experimental conditions.  
 
Primary Antibody Target Isotype Dilution Permeabilization Blocking Antibody Diluent 
Incubation 
time 
Secondary 
Antibody 
Incubation 
IC
C
 
Sarcomeric α-Actinin 
(A7811, Sigma-Aldrich) 
CMs’ sarcomeres 
(Z-lines) 
Mouse 
IgG 1:600 - 
- 
0.02% 
Tween-20 
in PBS 
1-2h, on ice 40min, on ice Phospho-Histone H3 
(Ser10; pH3) 
(#3377, Cell Signaling) 
Proliferation marker 
(mitosis) 
Rabbit 
IgG 1:800 
0.5% Triton X-100 
7 min 
IH
C
 
Sarcomeric α-Actinin 
(A7811, Sigma-Aldrich) 
CMs’ sarcomeres 
(Z-lines) 
Mouse 
IgG 1:500 - 
Mouse Ig 
Blocking 
Reagent 
(M.O.M., 
Vector 
Laboratories) 
 
1h, RT 
1% BSA + 
4% FBS in 
PBS 
ON, 4ºC 1h, RT 
Phospho-Histone H3  
(Ser10; pH3) 
(#3377, Cell Signaling) 
Proliferation marker 
(mitosis) 
Rabbit 
IgG 1:800 
1% Triton X-100 
5 min 
Ki67 
(ab15580, abcam) 
Proliferation marker 
(G1, S, G2, mitosis) 
Rabbit 
IgG 1:200 
0.2% Triton X-100 
5 min 
CD45 
(AF114, R&D Systems) 
Nucleated 
hematopoietic cells 
Goat 
IgG 1:300 - 
Connexin-43 
(ab11369, abcam) 
CMs’ gap junction 
protein 
Goat 
IgG 1:400 - 
Laminin 
(L9393, Sigma-Aldrich) 
Extracellular matrix 
glycoprotein 
Rabbit 
IgG 1:350 - 
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ImageStreamX: CMs’ quantification and morphometric 
characterization 
ImageStreamX (Amnis Corporation) was used for imaging cells (fluorescence and 
brightfield) with 40x magnification through a 488nm-laser excitation line. INSPIRE™ 
(Amnis) software was used for sample acquisition and IDEAS™ (Amnis) for data 
processing and analysis. Cell classifiers of 100 µm2 (for embryonic stages) and 150 µm2 
(for postnatal stages) were set on the area-lower limit of all the imagery channels, during 
data acquisition of a minimum of 50000 events. 
After acquisition, analysis is initiated with the gating of the sampled cell population 
for the actinin+ population, which corresponds to the percentage of cardiomyocytes 
present in the sample (Fig.7A). Cell populations were then hierarchically gated for single-
cells (excluding doublets and clusters) that were focused (Fig.7B) and were 
actinin+/DRAQ5+, to which the analysis’ template was applied (Fig.7C). Cells were also 
classified as “round” or “rod” whether its minor axis:major axis ratio was higher or lower 
than 0.55 respectively. The multi-parametric analysis is based on masks, in which a set 
of pixels is defined for a specific region of interest (e.g. nucleus and cytoplasm) and used 
to calculate feature-specific values from the acquired imagery. On the brightfield single 
images, masks (function “morphology mask”) delimiting the entire cellular area were 
created, to calculate the CMs’ area, major and minor axes and the proportion of round 
and rod-like shaped cells. The number of nuclei was manually calculated using the 
imagery obtained with ImageStreamX system. 
 
 
 
Fig.7 - Identification of CMs using IDEAS™ (Amnis) software. (A) The percentage of CMs present in the cell 
suspension was determined based on the frequency of Actinin expression. (B) Gating strategy used to exclude events 
that were not in focus (left panel) and cell doublets (middle panel). (C) To select the CMs population for further analysis 
actinin+/DRAQ5®+ subpopulation was selected (right panel).   
A B C 
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Gelatin embedding of murine hearts for Cryosectioning 
To perform immunohistochemistry (IHC), murine hearts were embedded in gelatin 
for cryosectioning. Hearts were fixed ON at 4ºC in 0.2% (v/v) PFA in 0.2 M phosphate 
buffer (PB - 0.2 M Na2HPO4 and 0.2 M NaH2PO4·H2O) with 0.12 mM CaCl2 and 
4% sucrose. In the following day, hearts were transferred to PB with 4% sucrose, and 
then to PB with 15% sucrose, with both incubations being carried on ON at 4ºC. Hearts 
were then incubated in PB with 15% sucrose and 7.5% gelatin for 1 hour at 37 ºC, after 
which they were transferred to an embedding mold filled with warm gelatin solution, to 
be frozen in dry ice-chilled isopentane and stored at -80 ºC, until sectioning. 
Gelatin-embedded hearts were cut longitudinally on a cryostat (Microm HM550, 
Thermo Fisher Scientific), into 5 μm-thick serial sections collected on Superfrost® Plus 
slides, air-dried for at least 30 min, and then stored at -80 ºC. 
 
 
Immunohistochemistry 
Heart cryosections were washed three times in PBS, 5 min each wash, and 
permeated for 5 min with Triton X-100: a final concentration of either 0.2% or 1% was 
used for cell membrane or cytoplasmic staining and intra-nuclear staining, respectively. 
Sections were blocked with Mouse Ig Blocking Reagent (Vector Laboratories) for 1 hour 
at RT. Antibodies (Table 2) were diluted in 1% bovine serum albumin (BSA) with 4% FBS 
in PBS. Primary antibody incubation was made ON at 4°C, followed by washes with PBS 
and a 1 hour-incubation at RT with the corresponding secondary antibodies (1:1000, Life 
Technologies), both in humid chambers. Slides were then mounted with Fluoroshield™ 
(Sigma-Aldrich) mounting medium with DAPI, and sealed after cover-slipping. 
Image acquisition was performed using IN Cell Analyzer 2000® system 
(GE Healthcare) (20x and 40x magnification). The obtained imagery was used to quantify 
the number of cell cycle active (Ki67-expressing) and mitotic (pH3-expressing) cells 
within the CMs population along ontogeny. Direct counting was performed on 
ImageJ/Fiji® software, and the numbers were expressed per mm2 of whole-heart, atria or 
ventricle.  
  
FCUP 
Restoring the heartbeat: Tracking cardiomyocyte proliferation 21 
 
Data and statistical analysis  
Statistical analysis was performed with SPSS® Statistics v22.0 (IBM). After testing 
for normality, Kruskal-Wallis test (for non-parametric data), one way analysis of variance 
(ANOVA) with post hoc Tukey's test and Student’s unpaired t-test (both for parametric 
data) was chosen as appropriate, to determine whether differences between the groups 
were significant. p≤0.05 was considered statistically significant. Data are presented as 
mean ± standard deviation (SD).
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RESULTS 
CMs’ morphometric and nuclear dynamics: characterization 
along ontogeny 
Heart development entails a gradual increase of the tissue’s complexity, as the 
cellular diversity increases and CMs enlarge and mature. As the heart matures, CMs’ 
cytoarchitecture undergoes drastic rearrangement. This event results in the sarcomeres’ 
assembly, transition from a round to a rod-like morphology and the formation and 
reorganization of intercalated discs (ICD) to the cell’s apical ends. This growing 
complexity (and thus difficulty in identifying CMs) can be easily appreciated by 
immunohistochemistry (IHC) in heart sections of distinct ontogenic stages. By performing 
IHC for CMs’ cytocomponents sarcomeric α-actinin (present in the sarcomeres’ Z-lines), 
connexin-43 (present in ICD for cell-cell contact) and laminin (a common extracellular 
matrix glycoprotein), the difficulties in accurately isolating CMs by identifying their 
borders are clear (Fig. 8). This approach has, however, been used by distinct 
laboratories to measure CMs and to quantify CMs number, which can lead to 
misestimating. 
With the goal of performing a detailed characterization of CMs morphometric 
dynamics throughout ontogeny, we have decided to further optimize a novel protocol for 
isolation of CMs, based on the work of Mollova et al. (2013), in which flash-frozen heart 
tissue blocks are enzymatically digested with collagenase II at 37ºC, after fixing. This 
protocol was used to isolate CMs of distinct ontogenic stages (Fig. 9A). It allows to obtain 
high yield of well-isolated CMs (Fig. 9B) with intact morphology and sarcomeric 
apparatus, which was validated by performing cytospins of the isolated cells and 
immunocitochemistry (ICC) for sarcomeric α-actinin and DAPI (Fig. 9C). Cell 
fragmentation is observed when isolating CMs from the adult heart, as these cells are 
fully mature. To overcome this, we have tested different optimization steps, being that 
cardiac perfusion with 4% PFA provided a better preservation of the cells’ integrity after 
enzymatic digestion (Fig. 9C). Nonetheless, further optimization is still required.  
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Fig.8 - Increasing complexity of the heart tissue, depicted by the distribution of gap junction protein Connexin 43 
and the extracellular matrix protein Laminin, in the developing murine heart. Connexin-43 is firstly detected at E13.5 
surrounding the cell membrane, whereas in the adult stage it is mainly present in the intercalated discs (arrowheads). 
Laminin distribution is also dynamic, as in the earliest embryonic stages is limited to patches, then concentrating around 
the cells’ lateral borders. During heart development, CMs elongate and become tightly linked with other resident non-
cardiomyocytic cells (solid arrows), hindering nuclei and cell individualization to measure the cells’ dimensions (striated 
arrows). Representative images are provided Scale bar = 100 μm and 20 μm (inset). 
 
The morphometry of isolated CMs was analyzed using ImageStreamX, which 
combines the high-throughput power of flow cytometry with high-resolution imaging, thus 
allowing automatic acquisition of statistically robust data of a variety of cellular 
parameters. This strategy allowed analyzing a high percentage of CMs from each stage 
analyzed, which were identified based on actinin expression (see methods for detailed 
gating information) (Fig.10A,B). 
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Fig.9 - Optimization of CMs isolation from the adult murine heart. (A) Murine cardiac development, from the rightward-
looped linear tube (E10.5) to the fully developed four-chambered adult heart. Scale bar: 1 mm. (B) Cell yields obtained 
during isolation of CMs from developing hearts. Data shown as mean ± SD. (C) Cytospins of CMs suspensions obtained 
with the established isolation protocol, which results in a high yield of CMs with well-preserved morphology and sarcomeric 
apparatus. Perfusion with 4% PFA (P) results in CMs with better morphology than the ones obtained from non-perfused 
hearts (NP). CMs were identified through staining for sarcomeric-α-actinin (red) and DNA was stained with DAPI (blue). 
Scale bar: 20 μm. n(replicates):10,9,15,7,6,2,1,1,6,1 and details for replicability can be found in Supplementary Table 1.  
 
We have evaluated several cellular morpho-parameters, such as major and minor 
axes, area and aspect ratio (AR). Regarding cell aspect ratio, in the earliest stages 
analyzed (E10.5), the majority of CMs present a round morphology (~80%) (Fig.10C), 
corresponding to an AR of 1:1, as expected (Fig.10D,E). The remaining cells were 
considered to be elongated cells, even though they presented an immature morphology. 
The proportion of round CMs was maintained in fetal stages (E17.5) and decreased to 
about 50% following birth (P0, p<0.05) (Fig. 10C,D). Our data thus indicate that the 
beginning of the shift in the cells’ morphology occurs around birth (E17.5-P0), with the 
cells undergoing elongation, showing an AR of 2:1 or 3:1 (Fig.10C, D and E). Our 
analysis also evidenced the presence of a small fraction of round-shaped CMs at late 
ontogenic stages (Fig.10C, D and E), which were confirmed to be intact cells and not 
artifacts or fragmented cells. In the time-range here evaluated, the cells’ major axis 
almost doubled (~25 µm to ~47 µm, p≤0.0001), while minimal change in the cells’ minor 
axis was observed (~15 µm to ~22 µm), leading to a rod-shape morphology (Fig.10F 
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and E). Subsequently the cell area increased by almost three-fold, from ~280 µm2 to 
~775 µm2 (p≤0.001). 
Regarding CMs’ nuclear dynamics, ImageStreamX automatic analysis was not 
totally conclusive, as the software could not fully distinguish nuclei inside intact CMs from 
the ones existent in the cells’ surroundings resultant from fragmented cells. For this 
reason, we have manually quantified the number of nuclei using the obtained imagery 
(Fig.11A and B). Our data shows multinucleation as starting around E17.5, with ~2% of 
the cells presenting two nuclei until P3 (Fig.11B). On the last time-point analyzed, P10, 
almost half of the cells (~48%) possess a single nucleus and the other half is 
multinucleated, presenting three (~1.5%) and four nuclei (~1%) (Fig. 11B). Interestingly, 
our analysis also evidenced a small subpopulation of mononucleated CMs that persist in 
the adult heart (Fig. 11B). Quantitative data for this stage is not presented due to the 
above mentioned difficulties in correctly isolating these cells.   
ImageStreamX analysis relies on user-defined masks outlining the pixels on which 
a given measurement will be made. To validate this automated tool, we manually 
validated the obtained results by immunocytochemistry on cytospun CMs with 
subsequent cell dimensions’ assessment using ImageJ/Fiji® software. In the time-range 
here assessed (E10.5-P10) our measurements confirmed an elongation event during 
CMs’ maturation. The major axis values increased by almost two-fold, from ~27 µm to 
~48 µm from E10.5 until P10 (p≤0.001). No substantial change (~16 µm to ~19 µm) was 
detected in the minor axis. The cell area doubled during the analyzed time-frame, from 
~297 µm2 to ~646 µm2 (p≤0.0001) (Fig.12A). Concerning CMs aspect ratio, in E10.5, the 
earliest embryonic stage here analyzed, both round (AR of 1:1 ~40%) and rod-shaped 
(AR higher than 1:1 ~60%) CMs were detected. In the last ontogenic stage here 
assessed (P10) the majority of the cells display high aspect ratios, related with rod-
morphology (~86%) and a small subset (~14% at P10) of round-shaped CMs with AR of 
1:1 (Fig.12B). Thus, the morphometric parameters evaluated (major and minor axes, 
aspect ratio and area) accurately resemble the ones obtained via ImageStreamX 
automatic analysis. 
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Fig.10 - ImageStreamX morphometric characterization of maturing CMs, obtained with the established isolation 
protocol. (A) Representative images of the CM analyzed using imaging flow cytometry; Scale bar: 10 μm. (B) CMs yield 
of the sampled suspensions. (C) Proportion of round and rod-shaped CMs throughout ontogeny. # p≤0.05 vs. E17.5; ** 
p≤0.01 vs. E10.5. (D) Dynamics of CMs aspect ratio along ontogeny. # p≤0.05 vs. E17.5, ### p≤0.001 vs. E17.5; * p≤0.05 
vs. E10.5, *** p≤0.001 vs. E10.5, **** p≤0.0001 vs. E10.5. (E) Representative images of round and rod-shaped CMs along 
ontogeny; Scale bar: 10 µm. (F) Analysis of morphometric parameters of the whole CM population and of the round and 
rod-shaped subsets. For purposes of illustration, only 500 randomly chosen events are represented, with the mean values 
corresponding to the total dataset. ♦, P3 vs. E10.5; ∆, P3 vs. E13.5. ♦,∆ p≤0.05; ♦♦,∆∆ p≤0.01; ♦♦♦,∆∆∆ p≤0.001; ♦♦♦♦ 
p≤0.0001 by one-way ANOVA with post hoc Tukey's test (C,F) or Kruskal-Wallis test (D). Data are shown as mean ± SD. 
n(assays)=4,3,6,4,3,1.Details for replicability can be found in Supplementary Table 1. 
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Fig.11 - CMs nuclear dynamics characterization along ontogeny. (A) Assessment of the number of nuclei per CMs 
obtained by direct counting using ImageStreamX imagery. * p≤0.05 vs. E10.5 or E13.5, one-way ANOVA with post hoc 
Tukey's test. (B) Representative images of multinucleated P10 cells, and mono- and binucleated adult CMs. Data 
presented as mean ± SD. n(assays)=4,3,6,4,3,1 (A). Details for replicability can be found in Supplementary Table 1. 
 
Fig.12 - Assessment of cellular dimensions during embryonic and early postnatal development in cytospins of 
maturing CMs. (A) Analysis of the morphometric dynamics of the total CMs population and of the round and rod-shaped 
subpopulation. *, P10 vs. E10.5; ∆, P10 vs. E13.5. , ***,∆∆∆ p≤0.001,  ****,∆∆∆∆ p≤0.0001. (B) Round (AR ≤ 1:1) and rod-
shaped (AR = 2:1 and ≥ 3:1) CMs proportions throughout ontogeny. * p≤0.05 vs. E10.5.  Data are shown as mean ± SD. 
n(assays)=4,3,6,4,3,1. Statistical significance evaluated by Kruskal-Wallis test (A) and one-way ANOVA with post hoc 
Tukey's test (A,B). Details for replicability can be found in Supplementary Table 1. 
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Characterization of CMs’ proliferation dynamics along ontogeny  
To assess the CMs’ cell cycle status and proliferation dynamics during 
development and determine the localization of proliferative CMs within the murine heart, 
we evaluated by IHC the expression of the classic proliferation markers Ki67 and 
phosphorylated-Histone H3 (pH3). Ki67 is a nuclear protein expressed during all the cell 
cycle active phases and absent in G0 (Gerdes et al., 1984). The phosphorylation of 
histone H3 marks the onset of mitosis (Goto et al., 2003). CMs were identified based on 
their specific staining for sarcomeric α-actinin. As the heart encompasses several other 
non-cardiomyocytic cells, such as hematopoietic cells (namely precursors of 
erythrocytes, leukocytes, macrophages and lymphocytes), which exhibit high rates of 
proliferation in the course of ontogeny (Orkin & Zon, 2008), CD45 marker was used to 
exclude the hematopoietic cardiac subpopulation from the analysis, avoiding 
overestimation of the proliferative CMs fraction (Fig.13). 
The frequency of Ki67 and pH3-expressing cells was then quantified by direct 
counting on the whole-heart, ventricles and atria (Fig.14). With this approach we 
quantified whole heart and CMs proliferation levels (Fig. 14A,B). During embryonic 
development (E10.5-E17.5) about 30% of CMs were Ki67 and ~15% pH3-positive in the 
whole-heart. At birth (P0), ~50% of CMs were Ki67-positive, while ~10% expressed pH3. 
Afterwards, a rapid decline of the cell cycle and mitosis-active CMs was observed until 
adulthood, in which ~0.26% and ~0.11% of CMs were Ki67 and pH3-positive respectively 
(Fig.14A). To complement this analysis, we evaluated the cell cycle status and 
proliferation rate within the cardiac chambers (Fig.14C,D). During prenatal development, 
the ventricles presented an increasing CMs proliferative activity, with rates of cell cycle 
active and mitotic CMs ranging between 25-50% and 9-12%, respectively (Fig.14C). The 
proliferation rate in the ventricular wall and atria then decreases steadily in the late 
postnatal stages, stabilizing below 0.3% in the adulthood (Fig.14C,D). Interestingly, two 
peaks of proliferation were detected in the atrial cardiomyocytic population, at E13.5 and 
P0. In the ventricles, proliferation levels were maintained from E13.5 to E17.5 and 
peaked also at P0 (Fig.14B).
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Fig. 13 - CMs’ cell cycle and proliferation dynamics throughout murine ontogeny. Assessment of Ki67-expressing (white) or pH3-expressing (white) CMs, which were identified though staining of the sarcomeric-α-actinin (red). CD45 staining (green) defines hematopoietic cells. Nuclei are counterstained 
with DAPI (blue). Representative images are provided and arrows point at Ki67 and pH3-positive CMs. Scale bars: 100 μm (E10.5-P10 whole-heart), 250 µm (P15-Adult whole-heart) and 50 µm (inset). 
a 
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Fig. 14 - Quantitative data of CMs’ proliferation and cell cycle status along murine ontogeny. Cell cycle active and 
proliferating total nuclei (A, Nuclei+) or CMs (B,C,D, CMs+) were assessed within the tissue by analyzing Ki67 and pH3 
expression, respectively, followed by direct counting on the whole-heart (A,B), atria (C) and ventricles (D) Inset graphs 
show in more detail the quantitation of the late ontogenic stages (P10 to adult), portraying the small extent of cell cycle 
active and mitotic CMs within heart. Data are expressed as the mean percentage of Ki67 and pH3-positive nuclei/CMs 
per square millimeter of whole-heart/atria/ventricle ± SD. n=4 distinct hearts were analyzed for each stage, except for P24 
in which only 2 hearts were evaluated. * vs. Adult, ♦ vs. P7.*,♦ p≤0.05,  **,♦♦ p≤0.01, *** p≤0.001, **** p≤0.0001 by Kruskal-
Wallis test. Details for replicability can be found in Supplementary Table 1.  
 
 
Due to the difficulties in accurately identifying CMs within the tissue, we validated 
the data obtained, through ICC on cytospun CMs for pH3 and sarcomeric-α-actinin and 
observed a decreasing number of mitotic CMs from E10.5 until E17.5 (Fig.15A,B). Even 
though preliminary, our results indicate that the followed staining strategy and 
quantification using IN Cell Analyzer 2000® constitutes a good tool to quantitate CMs’ 
proliferative extent.  
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Fig.15 - Immunocytochemical assessment of proliferation in cytospins of embryonic CMs.  (A) CMs were identified 
by sarcomeric-α-actinin staining (red) and analyzed by immunofluorescence for mitosis (pH3, green). Representative 
images are provided and the arrows point to proliferating CMs; Scale bar: 20 μm. (B) Quantification was made by direct 
counting of proliferating embryonic CMs in the total cell population and in the CMs subpopulation. Data presented as 
mean ± SD. n(assays)=3,3,1. Statistical significance was assessed with unpaired t-test, revealing non-significant (ns) 
differences between stages (t value=0.039). Details for replicability can be found in Supplementary Table 1.  
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DISCUSSION 
Cardiomyocytes are the key players that hold the essential task of maintaining the 
blood circulation, sustaining the homeostasis in vertebrates. The longstanding dogma of 
the postnatal mammalian heart being considered a post-mitotic organ, devoid of intrinsic 
regenerative capacity, has been challenged by recent reports of CMs renewal in the 
neonatal murine heart and in the adult human heart. Despite promising, these 
groundbreaking studies revealed discrepancies in CMs’ renewal extent due to difficulties 
in recognizing mammalian CMs’ nuclei, associated with the tissue’s complexity and due 
to the absence of specific surface markers to distinguish these cells from other native 
cells. 
As immunohistochemistry is hampered by the aforementioned hurdles, several 
CMs isolation protocols have been used by different laboratories, which normally include 
tedious protocols. However, a single universal isolation method that can be easily 
employed to routinely produce a large yield of high quality cells, regardless of the 
animals’ ontogenic stage, is still needed. This necessity was the major driving force that 
led our laboratory to optimize a novel CMs’ isolation protocol, based on the work of 
Mollova et al. (2013), which renders high-yield and high-quality CMs (Mollova et al., 
2013). This simple and rapid protocol consists of enzymatic digestion-rounds of 
flash-frozen and fixed cardiac tissue blocks, until full digestion is achieved. Using this 
protocol we were able to obtain a high yield of intact embryonic and neonatal CMs. 
However in the latest ontogenic stages, namely in the adult heart, fully mature CMs 
become fragmented during the digestion. Therefore, in the scope of this work we tested 
distinct alterations in the protocol and concluded that cardiac perfusion with 
paraformaldehyde allowed diminishing fragmentation during enzymatic digestion. 
Further optimization is still required, and it may include the use of connexins’ inhibitors 
to facilitate the cells’ dissociation by loss of cell-cell contacts. With this improved 
methodology we intend to create a benchmark, with which a large number of intact cells 
can be successfully obtained along ontogeny, enabling further studies to provide 
valuable insights into CMs’ cellular and sub-cellular physiology. Additionally, this protocol 
is also being used in other ongoing work in Perpétua Pinto-do-Ó laboratory with the goal 
of identifying specific CMs’ surface markers. 
The unique cytoarchitecture of CMs is drastically transformed over the course of 
ontogeny, from round to a fully developed rod-like shape. This correlates with cessation 
of the CMs’ proliferation ability, multinucleation (due to cytokinesis blockage), cell cycle 
withdrawal and cell hypertrophy. Recently, novel players in the multifactorial network of 
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these events have been brought to light, such as downregulation of cyclins-CDKs and 
mitosis-related genes (Tane et al., 2014a; Tane et al., 2014b), epigenetics (Oyama et 
al., 2014) and the high oxidative damage caused by ROS production due to the in utero 
hypoxia-to-normoxia transition as uncovered by Puente et al. (2014) body of work 
(Puente et al., 2014). The switch from a heart developmental hyperplasia to hypertrophy 
has been investigated in detail by Li et al. (1996). However no data is available when 
considering the relationship between CMs’ morphometry and proliferation ability during 
ontogeny. Likewise, comprehension and interpretation of the CMs’ cell cycle has been 
extremely challenging due to the aforementioned hurdles, and consequently many 
aspects of CMs maturation and proliferation remain unclear. Given this gap on 
knowledge, we set out to perform a detailed characterization of the morphometric, 
nuclear, cell cycle status and proliferation dynamics of CMs, throughout the maturation 
of the murine heart.  
We have performed a detailed analysis of the CMs’ cellular dimensions in the 
course of ontogeny using the ImageStreamX platform, which integrates the statistical 
power of large sample size analysis common to flow cytometry with the morphological 
features obtained by microscopy. To the best of our knowledge, this is the first report 
taking advantage of the unique abilities of ImageStreamX technology to characterize the 
cells’ morphometry (i.e. major and minor axes, cell area and aspect ratio) of developing 
murine CMs. This approach, that allows high-content and high-throughput analysis and 
quantification, was properly validated by manually evaluation of the same cellular 
morpho-parameters. The values obtained in both techniques were very similar, thus 
confirming ImageStreamX as a valuable tool to obtain consistent and reliable data. Our 
results evidence the drastic morphometric rearrangement that CMs undergo along 
ontogeny, with large modification of the cell’s major axis and minimal variation in the 
minor axis and concomitant increase of the cell’s area. According to Hirschy et al. (2006), 
this elongation phenomenon into a rod-like phenotype is consequence of rigorous 
alignment of the sarcomeric myofibrils to the cell’s major axis, required to enhance the 
cells’ contractile force to sustain the increasing heartbeat rate as the heart matures 
(Hirschy et al., 2006). 
In the postnatal mammalian heart, the majority of CMs are terminally differentiated 
and rod-shaped and our ImageStreamX data corroborate this widely accepted 
knowledge. Simultaneously with the occurrence of elongation, our results regarding 
CMs’ nuclear dynamics point to E17.5 as the starting point of the binucleation 
phenomenon (with ~1.5% binucleated cells). After P3 a burst of binucleation was also 
detected, which correlates with a final round of acytokinetic mitosis leading to cell cycle 
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arrest and CMs’ hypertrophic growth. This contrasts with the report of Soonpaa et al. 
(1996) that binucleation begins at P1 with ~5% of murine binucleated CMs, followed by 
a dramatic increase between P4-P7 (32%-88%) (Soonpaa et al., 1996). Recently, a 
refined study by Raulf et al. (2015) revealed distinct binucleation indexes between the 
adult murine ventricles (77-90%) and atria (14%), using a novel transgenic mice model 
expressing a fusion protein of human histone 2B and the red fluorescence protein 
mCherry under the control of the CMs specific α-MHC promoter (Raulf et al., 2015). The 
physiological and functional importance underlying binucleation is still poorly understood, 
but a possible explanation is that genome multiplication promotes cell survival under 
stressful conditions, through activation of DNA repair and protein turnover-related genes 
(Anatskaya & Vinogradov, 2007), while generating higher quantities of RNA transcripts 
to meet the hypertrophic CMs metabolic needs (Ahuja et al., 2007). 
One goal of this work was to characterize the cell cycle status and proliferation 
dynamics of the CMs population within the developing murine heart. Using 
immunohistochemical analysis, we were able to verify a gradual decrease of the cell 
cycle active and proliferating CMs subset from embryonic life until adulthood, consistent 
with the fact that CMs permanently exit the cell cycle by the end of the neonatal period, 
as they terminally differentiate (Walsh et al., 2010). Besides CMs, the permanent cellular 
constituents of the heart include cardiac fibroblasts, hematopoietic and endothelial cells 
and vascular smooth muscle cells. These non-cardiomyocytic lineages exhibit high rates 
of proliferation in the course of ontogeny, reason why its exclusion from the analysis is 
crucial. We used the hematopoietic cell marker CD45, and excluded cells that were 
circularly arranged or in large cords forming blood capillaries or vessels.  
Our data is in agreement with Kosaka et al. (2012), which quantitated the extent of 
pH3-positive CMs in sections of E12.5 whole heart, revealing a mitotic index of ~0.02 to 
~0.025 (ratio of the number of pH3+ nuclei to the total number of cells in the heart) 
(Kosaka et al., 2012). We report a mitotic index of ~0.01% at E13.5 whole heart and 
demonstrate decreasing CMs proliferation with heart maturation. Analysis of proliferation 
in cardiac chambers only, indicated that ventricular CMs are highly proliferative. This is 
consistent with their function as pulmonary-systemic blood pumping chambers, requiring 
proper wall thickening to keep up with the growing heartbeat rate. A mitotic index of 0.01-
0.02 in the E12.5 left ventricle was described by Kosaka et al. (2012), similarly to the 
mitotic index here obtained (~0.01) (Kosaka et al., 2012). In our analysis we identified 
two peaks of proliferation along mouse ontogeny: at E13.5 (atria only) and P0 (whole-
heart). 
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The proliferative peak detected at E13.5 correlates with myocardial growth and 
trabeculation of the ventricular wall, which serves primarily as a mean to increase 
myocardial oxygenation, while the coronary circulation is not fully developed (Wessels & 
Sedmera, 2003). At this stage, a top-to-base gradient of increasing proliferation arises 
with the basal compact myocardium displaying higher proliferating activity. The compact 
layer is relatively thin with highly proliferative CMs in S/G2/M phases whereas the 
trabecular myocardium comprises terminally differentiated CMs, predominantly arrested 
in G0/G1 phase (Park et al., 2013). At E13.5 another complex morphogenic event occurs 
in the right ventricle with the formation of the infundibulum, a funnel-shaped portion of 
the ventricle that opens into the developing pulmonary artery (Webb et al., 1998). Atrial 
CMs undergo a proliferative burst related with septation of the atrial chamber by 
formation of the atrial muscular septum. In the end, the primitive atrial chamber becomes 
fully divided in two individual compartments (Webb et al., 1998; Anderson et al., 2003; 
Moorman & Christoffels, 2003). The coincident growth of both cardiac chambers at E13.5 
is also correlated with the activation of the main cyclins and CDKs, therefore indicating 
an activation of the cell cycle and subsequent cell division, as reported by Ikenishi et al. 
(2012).  
The second proliferative burst here detected occurs at the day of birth (P0), with 
~50% of Ki67-positive and ~10% of pH3-positive CMs per mm2 of tissue. This peak of 
mitosis correlates with the 40% increase in the CMs population number recently 
described by Naqvi et al. (2014) during P0 until P4 (Naqvi et al., 2014). This work 
assessed the total number of CMs in both ventricles during mice ontogeny, by direct 
counting of enzymatic isolated-derived CMs. D'Uva et al. (2015) reported 0.5%-1% of 
pH3-positive CMs (using IHC) in the left ventricle cells of P1 hearts,(D'Uva et al., 2015). 
In agreement with this, at E17.5 by ICC we detect ~0.7% pH3-expressing CMs in the 
total cells. Regarding Ki67 expression, at P3 our data show that ~2.5% of CMs is Ki67-
positive, which is in line with the values previously obtained by flow cytometry (Walsh et 
al., 2010). Our findings, however, contradict Ikenishi and colleagues’ work, which 
reported that P0 presents the minimum expression levels of cyclins-CDKs in perinatal 
development (Ikenishi et al., 2012). Since no major morphogenic event is described to 
occur in the heart at birth, the peak of proliferation evidenced at P0 at first glance seems 
to result from CMs developmental hyperplasia to sustain the increasing hemodynamic 
load. Further studies are required to better understand the perinatal CMs’ proliferative 
burst, as it might unravel some clues about CMs’ terminal differentiation and proliferation 
cessation. In addition, our results shows that in neonatal hearts (P3-P7) the majority of 
CMs have acquired a cell cycle inactive status and no longer proliferate. Nonetheless, 
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from P3 onwards only ~20% of total CMs retains proliferative activity in the neonatal life, 
which is in agreement with the narrow time-window for heart regeneration in the first 
week of postnatal life reported by Porrello et al. (2011) using a apex resection-model 
(Porrello et al., 2011). 
Our data also allowed observing a modest frequency of Ki67 and pH3-expressing 
CMs in the late ontogeny, namely in the adult heart, in agreement with recent reports 
(Bergmann et al., 2009; Kajstura et al., 2010). This observation correlates well with our 
previous identification of a small subset of round and mononucleated CMs in late 
ontogenic stages, i.e. in the adult heart. These features are hallmark of embryonic 
myocytes. These results suggest the presence of an immature or less mature niche 
within the postnatal CMs pool, constituted of round mononucleated CMs, which 
reinforces previous studies reporting the identification of mitotic cardiac progenitors in 
the postnatal mammalian heart (Senyo et al., 2013). Whether these cells correspond to 
the small proliferative subset identified in the adult will be assessed by ImageStreamX, 
which we have proven to correctly distinguish round and rod-shaped CMs subsets. For 
this reason, the optimization of the CMs isolation protocol is crucial to obtain high cell 
quantity and quality in the adult stage. Additionally, evaluating the ploidy of the round 
mononucleated CMs here reported in the late developmental stages, would be of great 
interest in order to confirm if the cells are diploid, mimicking the embryonic karyotype. 
This would ratify once more its immatureness and potential to remain proliferative and 
play a role in CMs renewal in the adult mammalian heart. 
 
Overall, in the herein work we demonstrated that ImageStreamX can be used to 
accurately characterize CMs morphometry along ontogeny. Combination of this high-
throughput technique with immunohistochemistry allows obtaining quantitative data and 
cell-position information, respectively. Our approach evidenced the presence of 
immature or less differentiated niches of CMs within the murine heart, with features of 
the proliferative embryonic phenotype, such as small size, round shape and 
mononucleation. Characterization of these cells (and additional CMs subsets) is 
essential to achieve a better comprehension of CMs maturation and thus of the 
mechanisms underlying cell cycle blockage with differentiation. Ultimately, this will allow 
to understand if mature CMs can be reverted to a less mature state, re-acquiring a 
proliferative status.
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CONCLUSIONS 
 
Herein we aimed to characterize the dynamics of the CMs’ morphometry, nuclei, 
and proliferation in the course of mouse ontogeny, through a combination of powerful 
tools. In the scope of this study, we have (i) corroborated ImageStreamX as a valuable 
tool for high-content CMs analysis; (ii) improved the protocol for isolation of adult CMs, 
diminishing their fragmentation; (iii) demonstrated CMs’ elongation and binucleation 
starting at around E17.5, leading to fully mature rod-shaped and multinucleated cells, 
with up to four nuclei at P10; (iv) verified the presence of a small subset of 
mononucleated and round-shaped CMs in the late ontogenic stages, which may retain 
mitosis-competence; (iv) identified two peaks of proliferation, associated with cardiac 
chamber maturation; and finally, (v) confirmed a decrease in the number of cell cycle-
active and mitotic CMs, during ontogeny, with a small-extent of proliferation being 
detected in the adulthood.  
 
 
Globally, this work is a contribution towards a better understanding of the events 
underlying the relationship between CMs’ maturation, loss of proliferation and cell cycle 
withdrawal in the adult mammalian heart. Comprehending these mechanisms is crucial 
to shed light on the CMs’ cell cycle progression and withdrawal. It will also allow to verify 
the presence of putative niches of less-mature CMs, within the adult mammalian heart. 
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SUPPLEMENTAL MATERIAL 
Supplementary Table 1: Statistic data source. 
 n value 
Fig.9 
E10.5 10 / 80 
# Replicates / Hearts 
E13.5 9 / 72 
E17.5 15 / 15 
P0 7 / 7 
P3 6 6  
P10 2 / 2 
P15 1 / 1 
P24 1 / 1 
Adult (NP;P)* 6/6;1/1 
Fig.10 
E10.5 26463 
# CMs 
E13.5 44513 
E17.5 49036 
P0 36379 
P3 24157 
P10 5613 
Fig.12 
E10.5 414 
# CMs 
E13.5 281 
E17.5 319 
P0 156 
P3 386 
P10 94 
Fig.14 
 # Hearts Ki67 #Cells / Nuclei+ / CMs+ 
pH3 
#Cells / Nuclei+ / CMs+ 
E10.5 4 69853 / 538 / 324 28984 / 433 / 226 
E13.5 4 184783 / 4036 / 3006 90225 / 1233 / 658 
E17.5 4 248934 / 5684 / 4533 30675 / 2331 / 1452 
P0 4 320903 / 9773 / 7971 470018 / 5176 / 2789 
P3 4 563353 / 8138 / 5660 750793 / 2254 / 1109 
P7 4 527354 / 2609 / 1769 672691 / 1347 / 614 
P10 4 559128 / 1142 / 566 1033975 / 1144 / 558 
P15 4 964373 / 1930 / 1040 1725787 / 594 / 194 
P24 2 531547 / 238 / 113 228614 / 50 / 17 
Adult 4 1027624 / 833 / 273 1444320 / 439 / 120 
Fig.15 
E10.5 6889 / 1279 
# total cells / CMs E13.5 3907 / 1432 
E17.5 2371 / 1103 
*NP: non-perfused hearts; P: 4% PFA-perfused hearts. 
